Welcome
Support Centre
30 July 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Out of Hours Study: the effect of weekend and out-of-hours appointments on attendance rates at breast screening
ISRCTN ISRCTN70398358
ClinicalTrials.gov identifier
Public title Out of Hours Study: the effect of weekend and out-of-hours appointments on attendance rates at breast screening
Scientific title A multicentre randomised controlled study of the effect of weekend and out-of-hours appointments on attendance rates at breast screening
Acronym OOHS
Serial number at source N/A
Study hypothesis The primary purpose of the study is to discover whether the offer of weekend or out of hours screening appointments alters attendance rates, and if so, which is better, working hours appointments, weekday evening appointments or weekend appointments.

Women in Manchester and Bristol who are due a routine breast screening appointment will be randomised to trial arms, in which they will receive letters inviting them to an appointment in weekday working hours, an evening, a Saturday, or working hours with the option to change to an evening or Saturday. The measured endpoints for comparison will be overall attendance rates and attendance at first offered appointment.
Ethics approval Outer North East London Research Ethics Committee (REC) approved on the 15th March 2009 (ref: 09/H0701/96)
Study design Multicentre randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Breast cancer screening and prevention
Participants - inclusion criteria All women (aged 47-73 at Manchester, 50-70 at Bristol, the age range which is eligible for the screening programme at these sites) scheduled for invitation in batches to their next breast screening appointment by the participating centres.
Participants - exclusion criteria Does not meet inclusion criteria
Anticipated start date 01/01/2010
Anticipated end date 01/01/2011
Status of trial Ongoing
Patient information material
Target number of participants 18,000
Interventions There are no trial drugs or treatments associated with this trial.

Women who are due to be invited for breast screening in Manchester and Bristol will be allocated, based on month of birth, to one of 6 groups. These will then be randomised in a ratio of 3:1:1:1 to the following conditions:
1. Usual invitation letter to a routine screening appointment within working hours
2. Invitation letter to a routine screening appointment within working hours, but with the option of changing to an appointment on a weekend or on a weekday evening
3. Invitation letter to a weekday evening screening appointment
4. Invitation letter to a weekend appointment

The time taken between sending letters and initial appointment is 5 weeks, if appointments are changed then those within 120 days will be counted. Therefore the maximum length of time the patient could be in the study is 155 days.
Primary outcome measure(s) Attendance rate. Comparison will be made between the two major arms of the study, those with a working hours appointment offered, and those with an evening or weekend appointment. Attendance is defined as attending a screening appointment either at the time originally offered, or at an alternative appointment time within 120 days of the original. Data capture will include the appointment date and time offered, and the appointment date and time actually attended (if any).
Secondary outcome measure(s) 1. Whether the invitee attended the first appointment offered, measured by whether the radiographer records on the NBSS system database that the patient attended the original appointment (5 weeks after the invitation letter was sent out)
2. Comparison of the attendance rates between the four groups for subsets of the invitees. In particular, we shall evaluate the effect of the non-standard appointments at prevalence screen and by age group, but will also look at effects on incidence screens, previous attenders and previous non-attenders. This will be assessed using the attendance data collected from the primary outcome, and compared between the patient subsets.
Sources of funding NHS Breast Screening Programme National Office (UK)
Trial website http://www.cptu.co.uk/outofhours
Publications
Contact name Prof  Stephen  Duffy
  Address Cancer Research UK Centre for Epidemiology, Mathematics and Statistics
Wolfson Institute of Preventive Medicine
Barts and The London School of Medicine and Dentistry
Queen Mary, University of London
Charterhouse Square
  City/town London
  Zip/Postcode EC1M 6BQ
  Country United Kingdom
  Tel +44 (0)20 7882 3535
  Email s.w.duffy@qmul.ac.uk
Sponsor Queen Mary University of London (UK)
  Address Research & Development Office
Queen Mary Innovations Centre
Lower Ground Floor
5 Walden Street
  City/town London
  Zip/Postcode E1 2AN
  Country United Kingdom
  Tel +44 (0)20 7882 7260
  Email gerry.leonard@bartsandthelondon.nhs.uk
  Sponsor website: http://www.qmul.ac.uk/
Date applied 20/10/2009
Last edited 27/10/2009
Date ISRCTN assigned 27/10/2009
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central